When action movie star Chuck Norris earlier this month filed suit against firms involved in the distribution of gadolinium-based contrast agents, he put a human face on the gadolinium retention issue. MRI safety expert Dr. Emanuel Kanal of the University of Pittsburgh discusses the latest findings in what's known about gadolinium safety in this video.
Correction, Kanal Video 1 My MistakeVideo from RSNA 2017: Gadolinium retention debate takes center stage
Nov 28, 2017
Latest in Home
GLP-1 drugs reduce heart plaque progression in diabetes patients
December 1, 2025
Imaging can help 'All of Us'
December 1, 2025
GE HealthCare features new MRI scanners, PCCT system
December 1, 2025
Abdominal obesity linked to heart damage
December 1, 2025

















